Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.
2.

Regulation of alternative splicing by p300-mediated acetylation of splicing factors.

Siam A, Baker M, Amit L, Regev G, Rabner A, Najar RA, Bentata M, Dahan S, Cohen K, Araten S, Nevo Y, Kay G, Mandel-Gutfreund Y, Salton M.

RNA. 2019 Jul;25(7):813-824. doi: 10.1261/rna.069856.118. Epub 2019 Apr 15.

PMID:
30988101
3.

Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy.

Sheffer R, Gur M, Brooks R, Salah S, Daana M, Fraenkel N, Eisenstein E, Rabie M, Nevo Y, Jalas C, Elpeleg O, Edvardson S, Harel T.

Eur J Hum Genet. 2019 Apr 11. doi: 10.1038/s41431-019-0400-y. [Epub ahead of print]

PMID:
30976113
4.

Over 1-Year Followup of Laparoscopic Treatment of Enterovesical Fistula.

Nevo Y, Shapiro R, Froylich D, Meron-Eldar S, Zippel D, Nissan A, Hazzan D.

JSLS. 2019 Jan-Mar;23(1). pii: e2018.00095. doi: 10.4293/JSLS.2018.00095.

5.

Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.

Yosha-Orpaz N, Aharoni S, Rabie M, Nevo Y.

J Child Neurol. 2019 Apr;34(5):268-276. doi: 10.1177/0883073818825213. Epub 2019 Jan 23.

PMID:
30674221
6.

Cellulose Nanocrystals (CNCs) Induced Crystallization of Polyvinyl Alcohol (PVA) Super Performing Nanocomposite Films.

Ben Shalom T, Nevo Y, Leibler D, Shtein Z, Azerraf C, Lapidot S, Shoseyov O.

Macromol Biosci. 2019 Jan 23:e1800347. doi: 10.1002/mabi.201800347. [Epub ahead of print]

PMID:
30672646
7.

Liposomal steroid nano-drug is superior to steroids as-is in mdx mouse model of Duchenne muscular dystrophy.

Turjeman K, Yanay N, Elbaz M, Bavli Y, Gross M, Rabie M, Barenholz Y, Nevo Y.

Nanomedicine. 2019 Feb;16:34-44. doi: 10.1016/j.nano.2018.11.012. Epub 2018 Dec 7.

PMID:
30529791
8.

UV-Protection Timer Controls Linkage between Stress and Pigmentation Skin Protection Systems.

Malcov-Brog H, Alpert A, Golan T, Parikh S, Nordlinger A, Netti F, Sheinboim D, Dror I, Thomas L, Cosson C, Gonen P, Stanevsky Y, Brenner R, Perluk T, Frand J, Elgavish S, Nevo Y, Rahat D, Tabach Y, Khaled M, Shen-Orr SS, Levy C.

Mol Cell. 2018 Nov 1;72(3):444-456.e7. doi: 10.1016/j.molcel.2018.09.022. Epub 2018 Oct 25.

9.

Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer.

Granit RZ, Masury H, Condiotti R, Fixler Y, Gabai Y, Glikman T, Dalin S, Winter E, Nevo Y, Carmon E, Sella T, Sonnenblick A, Peretz T, Lehmann U, Paz K, Piccioni F, Regev A, Root DE, Ben-Porath I.

Cell Rep. 2018 Sep 18;24(12):3237-3250. doi: 10.1016/j.celrep.2018.08.053.

10.

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Conklin LS, Damsker JM, Hoffman EP, Jusko WJ, Mavroudis PD, Schwartz BD, Mengle-Gaw LJ, Smith EC, Mah JK, Guglieri M, Nevo Y, Kuntz N, McDonald CM, Tulinius M, Ryan MM, Webster R, Castro D, Finkel RS, Smith AL, Morgenroth LP, Arrieta A, Shimony M, Jaros M, Shale P, McCall JM, Hathout Y, Nagaraju K, van den Anker J, Ward LM, Ahmet A, Cornish MR, Clemens PR.

Pharmacol Res. 2018 Oct;136:140-150. doi: 10.1016/j.phrs.2018.09.007. Epub 2018 Sep 13.

11.

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.

Mizrachi T, Brill L, Rabie M, Nevo Y, Fellig Y, Zur M, Karussis D, Abramsky O, Brenner T, Vaknin-Dembinsky A.

J Immunol Res. 2018 May 22;2018:5389282. doi: 10.1155/2018/5389282. eCollection 2018.

12.

Modulation of caveolae by insulin/IGF-1 signaling regulates aging of Caenorhabditis elegans.

Roitenberg N, Bejerano-Sagie M, Boocholez H, Moll L, Marques FC, Golodetzki L, Nevo Y, Elami T, Cohen E.

EMBO Rep. 2018 Aug;19(8). pii: e45673. doi: 10.15252/embr.201745673. Epub 2018 Jun 26.

PMID:
29945933
13.
14.

APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.

Weisblum Y, Oiknine-Djian E, Zakay-Rones Z, Vorontsov O, Haimov-Kochman R, Nevo Y, Stockheim D, Yagel S, Panet A, Wolf DG.

J Virol. 2017 Nov 14;91(23). pii: e01296-17. doi: 10.1128/JVI.01296-17. Print 2017 Dec 1.

15.

Correction: Early age decline in DNA repair capacity in the liver: in depth profile of differential gene expression.

Guedj A, Geiger-Maor A, Benyamini H, Nevo Y, Elgavish S, Galun E, Amsalem H, Rachmilewitz J.

Aging (Albany NY). 2017 May 30;9(6):1640. doi: 10.18632/aging.101242. No abstract available.

16.

Evaluation of the IceTag leg sensor and its derivative models to predict behaviour, using beef cattle on rangeland.

Ungar ED, Nevo Y, Baram H, Arieli A.

J Neurosci Methods. 2018 Apr 15;300:127-137. doi: 10.1016/j.jneumeth.2017.06.001. Epub 2017 Jun 2.

PMID:
28583478
17.

Clonally stable Vκ allelic choice instructs Igκ repertoire.

Levin-Klein R, Fraenkel S, Lichtenstein M, Matheson LS, Bartok O, Nevo Y, Kadener S, Corcoran AE, Cedar H, Bergman Y.

Nat Commun. 2017 May 30;8:15575. doi: 10.1038/ncomms15575.

18.

Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.

Aharoni S, Sadeh M, Shapira Y, Edvardson S, Daana M, Dor-Wollman T, Mimouni-Bloch A, Halevy A, Cohen R, Sagie L, Argov Z, Rabie M, Spiegel R, Chervinsky I, Orenstein N, Engel AG, Nevo Y.

Neuromuscul Disord. 2017 Feb;27(2):136-140. doi: 10.1016/j.nmd.2016.11.014. Epub 2016 Nov 24.

19.

Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation.

Malakar P, Shilo A, Mogilevsky A, Stein I, Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV, Karni R.

Cancer Res. 2017 Mar 1;77(5):1155-1167. doi: 10.1158/0008-5472.CAN-16-1508. Epub 2016 Dec 19.

20.

Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface.

Weisblum Y, Oiknine-Djian E, Vorontsov OM, Haimov-Kochman R, Zakay-Rones Z, Meir K, Shveiky D, Elgavish S, Nevo Y, Roseman M, Bronstein M, Stockheim D, From I, Eisenberg I, Lewkowicz AA, Yagel S, Panet A, Wolf DG.

J Virol. 2017 Jan 31;91(4). pii: e01905-16. doi: 10.1128/JVI.01905-16. Print 2017 Feb 15.

21.

Early age decline in DNA repair capacity in the liver: in depth profile of differential gene expression.

Guedj A, Geiger-Maor A, Galun E, Benyamini H, Nevo Y, Elgavish Sh, Amsalem H, Rachmilewitz J.

Aging (Albany NY). 2016 Nov 30;8(11):3131-3146. doi: 10.18632/aging.101120. Erratum in: Aging (Albany NY). 2017 May 30;9(6):1640.

22.

Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel.

Aharoni S, Barwick KE, Straussberg R, Harlalka GV, Nevo Y, Chioza BA, McEntagart MM, Mimouni-Bloch A, Weedon M, Crosby AH.

BMC Med Genet. 2016 Nov 16;17(1):82.

23.

Highly Modified Cellulose Nanocrystals and Formation of Epoxy-Nanocrystalline Cellulose (CNC) Nanocomposites.

Abraham E, Kam D, Nevo Y, Slattegard R, Rivkin A, Lapidot S, Shoseyov O.

ACS Appl Mater Interfaces. 2016 Oct 19;8(41):28086-28095. doi: 10.1021/acsami.6b09852. Epub 2016 Oct 10.

PMID:
27704756
24.

Jejunal Diverticulitis.

Horesh N, Klang E, Gravetz A, Nevo Y, Amiel I, Amitai MM, Rosin D, Gutman M, Zmora O.

J Laparoendosc Adv Surg Tech A. 2016 Aug;26(8):596-9. doi: 10.1089/lap.2016.0066. Epub 2016 May 16. Review.

PMID:
27182822
25.

The Genetic Program of Pancreatic β-Cell Replication In Vivo.

Klochendler A, Caspi I, Corem N, Moran M, Friedlich O, Elgavish S, Nevo Y, Helman A, Glaser B, Eden A, Itzkovitz S, Dor Y.

Diabetes. 2016 Jul;65(7):2081-93. doi: 10.2337/db16-0003. Epub 2016 Mar 18.

26.

Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing.

Falaleeva M, Pages A, Matuszek Z, Hidmi S, Agranat-Tamir L, Korotkov K, Nevo Y, Eyras E, Sperling R, Stamm S.

Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1625-34. doi: 10.1073/pnas.1519292113. Epub 2016 Mar 8.

27.

p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.

Helman A, Klochendler A, Azazmeh N, Gabai Y, Horwitz E, Anzi S, Swisa A, Condiotti R, Granit RZ, Nevo Y, Fixler Y, Shreibman D, Zamir A, Tornovsky-Babeay S, Dai C, Glaser B, Powers AC, Shapiro AM, Magnuson MA, Dor Y, Ben-Porath I.

Nat Med. 2016 Apr;22(4):412-20. doi: 10.1038/nm.4054. Epub 2016 Mar 7.

28.

Nanocellulose, a tiny fiber with huge applications.

Abitbol T, Rivkin A, Cao Y, Nevo Y, Abraham E, Ben-Shalom T, Lapidot S, Shoseyov O.

Curr Opin Biotechnol. 2016 Jun;39:76-88. doi: 10.1016/j.copbio.2016.01.002. Epub 2016 Feb 28. Review.

PMID:
26930621
29.

Spinal muscular atrophy: A preliminary result toward new therapy.

Nevo Y, Wang C.

Neurology. 2016 Mar 8;86(10):884-5. doi: 10.1212/WNL.0000000000002453. Epub 2016 Feb 10. No abstract available.

PMID:
26865521
30.

Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function.

Haziza S, Magnani R, Lan D, Keinan O, Saada A, Hershkovitz E, Yanay N, Cohen Y, Nevo Y, Houtz RL, Sheffield VC, Golan H, Parvari R.

PLoS Genet. 2015 Aug 6;11(8):e1005388. doi: 10.1371/journal.pgen.1005388. eCollection 2015 Aug.

31.

Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency.

Ben-Zeev B, Tabib A, Nissenkorn A, Garti BZ, Gomori JM, Nass D, Goldshmidt H, Fellig Y, Anikster Y, Nevo Y, Elpeleg O, Mevorach D.

Eur J Paediatr Neurol. 2015 Nov;19(6):688-93. doi: 10.1016/j.ejpn.2015.07.001. Epub 2015 Jul 20.

PMID:
26233519
32.

Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.

Rokach O, Sekulic-Jablanovic M, Voermans N, Wilmshurst J, Pillay K, Heytens L, Zhou H, Muntoni F, Gautel M, Nevo Y, Mitrani-Rosenbaum S, Attali R, Finotti A, Gambari R, Mosca B, Jungbluth H, Zorzato F, Treves S.

Hum Mol Genet. 2015 Aug 15;24(16):4636-47. doi: 10.1093/hmg/ddv195. Epub 2015 May 27.

PMID:
26019235
33.

Ileo-colonic intussusception.

Nevo Y, Lebedyev A, Nevler A.

ANZ J Surg. 2015 Oct;85(10):786-7. doi: 10.1111/ans.13052. Epub 2015 Mar 12. No abstract available.

PMID:
25766499
34.

Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.

Elbaz M, Yanay N, Laban S, Rabie M, Mitrani-Rosenbaum S, Nevo Y.

Cell Death Dis. 2015 Mar 12;6:e1690. doi: 10.1038/cddis.2015.60.

35.

Nerve growth factor-induced myoprotection in C2C12 muscle cells is mediated by α9β1 integrin via release of PGE2.

Ettinger K, Nevo Y, Marcinkiewicz C, Lazarovici P.

J Basic Clin Physiol Pharmacol. 2015 Jul;26(4):411-5. doi: 10.1515/jbcpp-2014-0111.

PMID:
25741790
36.

Heat shock activates splicing at latent alternative 5' splice sites in nematodes.

Nevo Y, Sperling J, Sperling R.

Nucleus. 2015;6(3):225-35. doi: 10.1080/19491034.2015.1010956. Epub 2015 Jan 29.

37.

Variable myopathic presentation in a single family with novel skeletal RYR1 mutation.

Attali R, Aharoni S, Treves S, Rokach O, Becker Cohen M, Fellig Y, Straussberg R, Dor T, Daana M, Mitrani-Rosenbaum S, Nevo Y.

PLoS One. 2013 Jul 24;8(7):e69296. doi: 10.1371/journal.pone.0069296. Print 2013.

38.

Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy.

Ravenscroft G, Miyatake S, Lehtokari VL, Todd EJ, Vornanen P, Yau KS, Hayashi YK, Miyake N, Tsurusaki Y, Doi H, Saitsu H, Osaka H, Yamashita S, Ohya T, Sakamoto Y, Koshimizu E, Imamura S, Yamashita M, Ogata K, Shiina M, Bryson-Richardson RJ, Vaz R, Ceyhan O, Brownstein CA, Swanson LC, Monnot S, Romero NB, Amthor H, Kresoje N, Sivadorai P, Kiraly-Borri C, Haliloglu G, Talim B, Orhan D, Kale G, Charles AK, Fabian VA, Davis MR, Lammens M, Sewry CA, Manzur A, Muntoni F, Clarke NF, North KN, Bertini E, Nevo Y, Willichowski E, Silberg IE, Topaloglu H, Beggs AH, Allcock RJ, Nishino I, Wallgren-Pettersson C, Matsumoto N, Laing NG.

Am J Hum Genet. 2013 Jul 11;93(1):6-18. doi: 10.1016/j.ajhg.2013.05.004. Epub 2013 Jun 6.

39.

CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.

Nevo Y, Ben-Zeev B, Tabib A, Straussberg R, Anikster Y, Shorer Z, Fattal-Valevski A, Ta-Shma A, Aharoni S, Rabie M, Zenvirt S, Goldshmidt H, Fellig Y, Shaag A, Mevorach D, Elpeleg O.

Blood. 2013 Jan 3;121(1):129-35. doi: 10.1182/blood-2012-07-441857. Epub 2012 Nov 13.

40.

Genome-wide activation of latent donor splice sites in stress and disease.

Nevo Y, Kamhi E, Jacob-Hirsch J, Amariglio N, Rechavi G, Sperling J, Sperling R.

Nucleic Acids Res. 2012 Nov;40(21):10980-94. doi: 10.1093/nar/gks834. Epub 2012 Sep 23.

41.

Nerve growth factor stimulation of ERK1/2 phosphorylation requires both p75NTR and α9β1 integrin and confers myoprotection towards ischemia in C2C12 skeletal muscle cell model.

Ettinger K, Lecht S, Arien-Zakay H, Cohen G, Aga-Mizrachi S, Yanay N, Saragovi HU, Nedev H, Marcinkiewicz C, Nevo Y, Lazarovici P.

Cell Signal. 2012 Dec;24(12):2378-88. doi: 10.1016/j.cellsig.2012.08.008. Epub 2012 Aug 30.

PMID:
22960610
42.

Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse.

Elbaz M, Yanay N, Aga-Mizrachi S, Brunschwig Z, Kassis I, Ettinger K, Barak V, Nevo Y.

Ann Neurol. 2012 May;71(5):699-708. doi: 10.1002/ana.22694.

PMID:
22522482
43.

Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial.

Escolar DM, Zimmerman A, Bertorini T, Clemens PR, Connolly AM, Mesa L, Gorni K, Kornberg A, Kolski H, Kuntz N, Nevo Y, Tesi-Rocha C, Nagaraju K, Rayavarapu S, Hache LP, Mayhew JE, Florence J, Hu F, Arrieta A, Henricson E, Leshner RT, Mah JK.

Neurology. 2012 Mar 20;78(12):904-13. doi: 10.1212/WNL.0b013e31824c46be. Epub 2012 Mar 7.

44.

Early developmental cues for diagnosis of attention deficit/hyperactivity disorder in young children.

Berger I, Nevo Y.

Dev Disabil Res Rev. 2011;17(2):170-9. doi: 10.1002/ddrr.1111. Review.

PMID:
23362036
45.

Special issue on developmental delay.

Levy Y, Ornoy A, Nevo Y.

Dev Disabil Res Rev. 2011;17(2):57-8. doi: 10.1002/ddrr.1100.

PMID:
23362025
46.

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.

Escolar DM, Hache LP, Clemens PR, Cnaan A, McDonald CM, Viswanathan V, Kornberg AJ, Bertorini TE, Nevo Y, Lotze T, Pestronk A, Ryan MM, Monasterio E, Day JW, Zimmerman A, Arrieta A, Henricson E, Mayhew J, Florence J, Hu F, Connolly AM.

Neurology. 2011 Aug 2;77(5):444-52. doi: 10.1212/WNL.0b013e318227b164. Epub 2011 Jul 13.

47.

The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy.

Nevo Y, Aga-Mizrachi S, Elmakayes E, Yanay N, Ettinger K, Elbaz M, Brunschwig Z, Dadush O, Elad-Sfadia G, Haklai R, Kloog Y, Chapman J, Reif S.

PLoS One. 2011 Mar 22;6(3):e18049. doi: 10.1371/journal.pone.0018049.

48.

Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice.

Nevo Y, Halevy O, Genin O, Moshe I, Turgeman T, Harel M, Biton E, Reif S, Pines M.

Muscle Nerve. 2010 Aug;42(2):218-29. doi: 10.1002/mus.21706.

PMID:
20589893
49.

Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.

Dadush O, Aga-Mizrachi S, Ettinger K, Tabakman R, Elbaz M, Fellig Y, Yanay N, Nevo Y.

Neuromuscul Disord. 2010 Apr;20(4):267-72. doi: 10.1016/j.nmd.2010.02.002. Epub 2010 Mar 20.

PMID:
20304648
50.

Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis.

Attali R, Warwar N, Israel A, Gurt I, McNally E, Puckelwartz M, Glick B, Nevo Y, Ben-Neriah Z, Melki J.

Hum Mol Genet. 2009 Sep 15;18(18):3462-9. doi: 10.1093/hmg/ddp290. Epub 2009 Jun 19.

PMID:
19542096

Supplemental Content

Support Center